by Chemprotech | 9 Apr 2025 | News
Nearly two decades ago, South African researcher Kelly Chibale recalls participating in a pioneering World Health Organization (WHO) meeting in Abuja, Nigeria, organized by TDR, the WHO-hosted Special Programme for Research and Training in Tropical Diseases, focusing...
by Chemprotech | 9 Apr 2025 | Featured
There is an urgent need for Africa to develop local manufacturing capabilities for Active Pharmaceutical Ingredients (APIs) so as to reduce reliance on imports, enhance healthcare outcomes, and stimulate economic growth. But innovative technologies and international...
by Chemprotech | 9 Apr 2025 | News
The Medicines for All Institute has entered into a partnership with a manufacturer in South Africa to commercialize advances made by the institute to improve access to lifesaving medications for HIV/AIDS and other diseases. The institute, which has successfully...
by Chemprotech | 8 Apr 2025 | News
Though several South African companies are producing HIV and TB medicines, the active ingredients that go into these medicines are usually imported from India or China. Now, a local company is planning to break new ground by making the active ingredients for two...
by Chemprotech | 7 Apr 2025 | Featured
A pilot plant for the manufacture of generic active pharmaceutical ingredients (APIs) was officially opened in Pretoria on Friday. A R50-million joint project between local company CPT Pharma (CPT standing for Chemical Process Technologies), the Industrial Development...
